vs
Side-by-side financial comparison of Commerce.com, Inc. (CMRC) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
Commerce.com, Inc. is the larger business by last-quarter revenue ($89.5M vs $75.5M, roughly 1.2× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 2.9%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-2.2M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 5.5%).
SPS Commerce, Inc. is a technology and application software company based in the United States that provides cloud-based supply chain management software. The company's headquarters are located in Minneapolis, Minnesota, but it also has a US office in New Jersey, and international locations in Amsterdam, Beijing, Breukelen, Hong Kong, Kyiv, Melbourne, Montpellier, Sydney, and Toronto.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
CMRC vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $89.5M | $75.5M |
| Net Profit | $-8.4M | — |
| Gross Margin | 78.3% | 69.3% |
| Operating Margin | -7.4% | 22.7% |
| Net Margin | -9.3% | — |
| Revenue YoY | 2.9% | 27.7% |
| Net Profit YoY | -250.0% | — |
| EPS (diluted) | $-0.11 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $89.5M | $75.5M | ||
| Q3 25 | $86.0M | $54.5M | ||
| Q2 25 | $84.4M | $52.4M | ||
| Q1 25 | $82.4M | $46.0M | ||
| Q4 24 | $87.0M | $59.1M | ||
| Q3 24 | $83.7M | $80.5M | ||
| Q2 24 | $81.8M | $47.1M | ||
| Q1 24 | $80.4M | $43.8M |
| Q4 25 | $-8.4M | — | ||
| Q3 25 | $-2.2M | $8.8M | ||
| Q2 25 | $-8.4M | $5.9M | ||
| Q1 25 | $-353.0K | $3.0M | ||
| Q4 24 | $-2.4M | — | ||
| Q3 24 | $-7.0M | $20.3M | ||
| Q2 24 | $-11.3M | $-4.5M | ||
| Q1 24 | $-6.4M | $-4.8M |
| Q4 25 | 78.3% | 69.3% | ||
| Q3 25 | 78.4% | 77.7% | ||
| Q2 25 | 79.0% | 76.5% | ||
| Q1 25 | 79.4% | 77.1% | ||
| Q4 24 | 77.6% | 76.4% | ||
| Q3 24 | 76.3% | 63.9% | ||
| Q2 24 | 75.8% | 77.4% | ||
| Q1 24 | 77.1% | 75.5% |
| Q4 25 | -7.4% | 22.7% | ||
| Q3 25 | -0.5% | 17.6% | ||
| Q2 25 | -8.0% | 12.7% | ||
| Q1 25 | -2.9% | 8.7% | ||
| Q4 24 | -0.9% | 22.6% | ||
| Q3 24 | -23.0% | 27.4% | ||
| Q2 24 | -16.5% | -4.6% | ||
| Q1 24 | -10.2% | -5.3% |
| Q4 25 | -9.3% | — | ||
| Q3 25 | -2.6% | 16.2% | ||
| Q2 25 | -9.9% | 11.2% | ||
| Q1 25 | -0.4% | 6.5% | ||
| Q4 24 | -2.7% | — | ||
| Q3 24 | -8.4% | 25.2% | ||
| Q2 24 | -13.8% | -9.6% | ||
| Q1 24 | -8.0% | -11.0% |
| Q4 25 | $-0.11 | $0.26 | ||
| Q3 25 | $-0.03 | $0.17 | ||
| Q2 25 | $-0.10 | $0.12 | ||
| Q1 25 | $0.00 | $0.06 | ||
| Q4 24 | $-0.03 | $0.40 | ||
| Q3 24 | $-0.09 | $0.41 | ||
| Q2 24 | $-0.15 | $-0.09 | ||
| Q1 24 | $-0.08 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $141.1M | $97.5M |
| Total DebtLower is stronger | $157.0M | $22.7M |
| Stockholders' EquityBook value | $39.4M | $130.3M |
| Total Assets | $308.8M | $216.3M |
| Debt / EquityLower = less leverage | 3.99× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $141.1M | $97.5M | ||
| Q3 25 | $142.0M | $94.4M | ||
| Q2 25 | $134.5M | $96.0M | ||
| Q1 25 | $120.7M | $93.2M | ||
| Q4 24 | $178.2M | $101.0M | ||
| Q3 24 | $168.4M | $96.7M | ||
| Q2 24 | $275.8M | $96.8M | ||
| Q1 24 | $265.2M | $107.2M |
| Q4 25 | $157.0M | $22.7M | ||
| Q3 25 | $157.3M | $34.0M | ||
| Q2 25 | $157.5M | $45.3M | ||
| Q1 25 | $157.8M | $56.7M | ||
| Q4 24 | $216.5M | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | $340.9M | $90.7M | ||
| Q1 24 | $340.5M | $102.0M |
| Q4 25 | $39.4M | $130.3M | ||
| Q3 25 | $42.8M | $115.3M | ||
| Q2 25 | $38.8M | $104.7M | ||
| Q1 25 | $38.1M | $97.1M | ||
| Q4 24 | $33.4M | $92.1M | ||
| Q3 24 | $29.0M | $71.1M | ||
| Q2 24 | $26.1M | $48.5M | ||
| Q1 24 | $26.9M | $51.0M |
| Q4 25 | $308.8M | $216.3M | ||
| Q3 25 | $309.5M | $202.9M | ||
| Q2 25 | $302.5M | $194.9M | ||
| Q1 25 | $286.3M | $196.2M | ||
| Q4 24 | $340.3M | $213.3M | ||
| Q3 24 | $335.1M | $220.7M | ||
| Q2 24 | $452.5M | $205.0M | ||
| Q1 24 | $442.5M | $214.1M |
| Q4 25 | 3.99× | 0.17× | ||
| Q3 25 | 3.67× | 0.30× | ||
| Q2 25 | 4.06× | 0.43× | ||
| Q1 25 | 4.14× | 0.58× | ||
| Q4 24 | 6.49× | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | 13.06× | 1.87× | ||
| Q1 24 | 12.65× | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $980.0K | $14.4M |
| Free Cash FlowOCF − Capex | $-2.2M | $14.4M |
| FCF MarginFCF / Revenue | -2.4% | 19.1% |
| Capex IntensityCapex / Revenue | 3.5% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $16.9M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $980.0K | $14.4M | ||
| Q3 25 | $10.6M | $9.7M | ||
| Q2 25 | $13.6M | $14.1M | ||
| Q1 25 | $401.0K | $3.6M | ||
| Q4 24 | $12.4M | $15.6M | ||
| Q3 24 | $5.6M | $11.0M | ||
| Q2 24 | $11.7M | $1.0M | ||
| Q1 24 | $-3.4M | $11.2M |
| Q4 25 | $-2.2M | $14.4M | ||
| Q3 25 | $7.6M | $9.7M | ||
| Q2 25 | $11.9M | $14.1M | ||
| Q1 25 | $-424.0K | $3.6M | ||
| Q4 24 | $11.6M | $15.6M | ||
| Q3 24 | $4.5M | $11.0M | ||
| Q2 24 | $10.7M | $1.0M | ||
| Q1 24 | $-4.2M | — |
| Q4 25 | -2.4% | 19.1% | ||
| Q3 25 | 8.8% | 17.7% | ||
| Q2 25 | 14.1% | 26.8% | ||
| Q1 25 | -0.5% | 7.7% | ||
| Q4 24 | 13.3% | 26.4% | ||
| Q3 24 | 5.4% | 13.7% | ||
| Q2 24 | 13.0% | 2.1% | ||
| Q1 24 | -5.3% | — |
| Q4 25 | 3.5% | 0.0% | ||
| Q3 25 | 3.4% | 0.0% | ||
| Q2 25 | 2.0% | 0.0% | ||
| Q1 25 | 1.0% | 0.1% | ||
| Q4 24 | 0.9% | 0.0% | ||
| Q3 24 | 1.3% | 0.0% | ||
| Q2 24 | 1.3% | 0.0% | ||
| Q1 24 | 1.0% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CMRC
| Subscription And Circulation | $65.2M | 73% |
| Partner And Services | $24.4M | 27% |
PBYI
Segment breakdown not available.
